Awad, Wael, Abdelaal, Mohamed R., Letoga, Victoria, McCluskey, James and Rossjohn, Jamie ![]() ![]() |
![]() |
PDF
- Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (4MB) |
Abstract
The major histocompatibility complex class‐I related protein, MR1, is an evolutionarily conserved antigen presenting molecule that binds and displays organic metabolites to T cells, including mucosal associated invariant T (MAIT) cells and diverse MR1‐restricted T cells (MR1T). Structural studies have elucidated how MR1 can accommodate a range of chemical scaffolds that arise from foreign, synthetic, and self‐metabolites, although the full spectrum of metabolites that MR1 presents remains unclear. Presently, MAIT and MR1T cell recognition of MR1‐antigen complexes represents a new immune recognition paradigm and is emerging as a critical player in protective immunity, aberrant immunity, tumor immunity, and tissue repair. Moreover, the limited allelic variation of MR1 makes it an attractive therapeutic target. This review will address the unique features and capability of the MR1 molecule to display several classes of small molecules for T cell surveillance. We will also address the molecular basis underlying MAIT and MR1T TCR recognition of MR1‐binding ligands.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Schools > Medicine |
Additional Information: | License information from Publisher: LICENSE 1: URL: http://creativecommons.org/licenses/by-nc-nd/4.0/ |
Publisher: | Wiley |
ISSN: | 0105-2896 |
Date of First Compliant Deposit: | 14 May 2025 |
Date of Acceptance: | 11 April 2025 |
Last Modified: | 14 May 2025 09:30 |
URI: | https://orca.cardiff.ac.uk/id/eprint/178270 |
Actions (repository staff only)
![]() |
Edit Item |